These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 2839663

  • 1. Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscle.
    Ignarro LJ, Buga GM, Byrns RE, Wood KS, Chaudhuri G.
    J Pharmacol Exp Ther; 1988 Jul; 246(1):218-26. PubMed ID: 2839663
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation.
    Ignarro LJ, Byrns RE, Buga GM, Wood KS, Chaudhuri G.
    J Pharmacol Exp Ther; 1988 Jan; 244(1):181-9. PubMed ID: 2826766
    [Abstract] [Full Text] [Related]

  • 3. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical.
    Ignarro LJ, Byrns RE, Buga GM, Wood KS.
    Circ Res; 1987 Dec; 61(6):866-79. PubMed ID: 2890446
    [Abstract] [Full Text] [Related]

  • 4. EDRF generation and release from perfused bovine pulmonary artery and vein.
    Ignarro LJ, Buga GM, Chaudhuri G.
    Eur J Pharmacol; 1988 Apr 27; 149(1-2):79-88. PubMed ID: 3135198
    [Abstract] [Full Text] [Related]

  • 5. Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid.
    Ignarro LJ, Harbison RG, Wood KS, Kadowitz PJ.
    J Pharmacol Exp Ther; 1986 Jun 27; 237(3):893-900. PubMed ID: 2872327
    [Abstract] [Full Text] [Related]

  • 6. Acetylcholine stimulates release of endothelium-derived relaxing factor in coronary arteries of human organ donors.
    Blaise GA, Stewart DJ, Guérard MJ.
    Can J Cardiol; 1993 Nov 27; 9(9):813-20. PubMed ID: 8281481
    [Abstract] [Full Text] [Related]

  • 7. Endothelium-derived relaxing factor is a selective relaxant of vascular smooth muscle.
    Shikano K, Berkowitz BA.
    J Pharmacol Exp Ther; 1987 Oct 27; 243(1):55-60. PubMed ID: 3499504
    [Abstract] [Full Text] [Related]

  • 8. Association between cyclic GMP accumulation and acetylcholine-elicited relaxation of bovine intrapulmonary artery.
    Ignarro LJ, Burke TM, Wood KS, Wolin MS, Kadowitz PJ.
    J Pharmacol Exp Ther; 1984 Mar 27; 228(3):682-90. PubMed ID: 6323677
    [Abstract] [Full Text] [Related]

  • 9. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
    Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G.
    Proc Natl Acad Sci U S A; 1987 Dec 27; 84(24):9265-9. PubMed ID: 2827174
    [Abstract] [Full Text] [Related]

  • 10. Endothelium-derived relaxing factor (EDRF) from cultured and fresh endothelial cells.
    Gryglewski RJ, Trybulec M, Radziszewski W, Swierkosz T, Dudek R, Zembowicz A.
    Biomed Biochim Acta; 1988 Dec 27; 47(10-11):S61-6. PubMed ID: 2470361
    [Abstract] [Full Text] [Related]

  • 11. Relaxation of intrapulmonary artery and vein by nitrogen oxide-containing vasodilators and cyclic GMP.
    Edwards JC, Ignarro LJ, Hyman AL, Kadowitz PJ.
    J Pharmacol Exp Ther; 1984 Jan 27; 228(1):33-42. PubMed ID: 6319670
    [Abstract] [Full Text] [Related]

  • 12. Endothelium-derived nitric oxide relaxes nonvascular smooth muscle.
    Buga GM, Gold ME, Wood KS, Chaudhuri G, Ignarro LJ.
    Eur J Pharmacol; 1989 Feb 14; 161(1):61-72. PubMed ID: 2542037
    [Abstract] [Full Text] [Related]

  • 13. Superoxide dismutase does not improve penetration of endothelium-derived relaxing factor (EDRF) through the vessel wall.
    Gräser T, Vedernikov YP.
    Biomed Biochim Acta; 1989 Feb 14; 48(4):351-3. PubMed ID: 2787633
    [Abstract] [Full Text] [Related]

  • 14. [Two types of relaxation responses mediated by cyclic GMP in cerebral arteries].
    Kanamaru K, Waga S, Kojima T, Fujimoto K.
    No To Shinkei; 1989 Jun 14; 41(6):559-65. PubMed ID: 2553081
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Abluminal release and asymmetrical response of the rabbit arterial wall to endothelium-derived relaxing factor.
    Bassenge E, Busse R, Pohl U.
    Circ Res; 1987 Nov 14; 61(5 Pt 2):II68-73. PubMed ID: 3117407
    [Abstract] [Full Text] [Related]

  • 18. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.
    Palmer RM, Ferrige AG, Moncada S.
    Nature; 1987 Nov 14; 327(6122):524-6. PubMed ID: 3495737
    [Abstract] [Full Text] [Related]

  • 19. Inhibition by sulfhydryl compounds of vascular relaxation induced by nitric oxide and endothelium-derived relaxing factor.
    Jia L, Furchgott RF.
    J Pharmacol Exp Ther; 1993 Oct 14; 267(1):371-8. PubMed ID: 8229764
    [Abstract] [Full Text] [Related]

  • 20. Differences in responsiveness of intrapulmonary artery and vein to arachidonic acid: mechanism of arterial relaxation involves cyclic guanosine 3':5'-monophosphate and cyclic adenosine 3':5'-monophosphate.
    Ignarro LJ, Harbison RG, Wood KS, Wolin MS, McNamara DB, Hyman AL, Kadowitz PJ.
    J Pharmacol Exp Ther; 1985 Jun 14; 233(3):560-9. PubMed ID: 2989487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.